These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23320797)

  • 1. TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier.
    Stephan D; Sbai O; Wen J; Couraud PO; Putterman C; Khrestchatisky M; Desplat-Jégo S
    J Neuroinflammation; 2013 Jan; 10():9. PubMed ID: 23320797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation.
    Polavarapu R; Gongora MC; Winkles JA; Yepes M
    J Neurosci; 2005 Nov; 25(44):10094-100. PubMed ID: 16267216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice.
    Wen J; Chen CH; Stock A; Doerner J; Gulinello M; Putterman C
    Brain Behav Immun; 2016 May; 54():27-37. PubMed ID: 26721417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A further TWEAK to multiple sclerosis pathophysiology.
    Nazeri A; Heydarpour P; Sadaghiani S; Sahraian MA; Burkly LC; Bar-Or A
    Mol Neurobiol; 2014 Feb; 49(1):78-87. PubMed ID: 23873135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA Snhg3 contributes to dysfunction of cerebral microvascular cells in intracerebral hemorrhage rats by activating the TWEAK/Fn14/STAT3 pathway.
    Zhang J; Dong B; Hao J; Yi S; Cai W; Luo Z
    Life Sci; 2019 Nov; 237():116929. PubMed ID: 31610210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
    Wen J; Doerner J; Weidenheim K; Xia Y; Stock A; Michaelson JS; Baruch K; Deczkowska A; Gulinello M; Schwartz M; Burkly LC; Putterman C
    J Autoimmun; 2015 Jun; 60():40-50. PubMed ID: 25911200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
    Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C
    J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells.
    Harada N; Nakayama M; Nakano H; Fukuchi Y; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2002 Dec; 299(3):488-93. PubMed ID: 12445828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
    Haile WB; Echeverry R; Wu J; Yepes M
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tweak and FN14 in central nervous system health and disease.
    Yepes M
    Front Biosci; 2007 May; 12():2772-81. PubMed ID: 17485258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.
    Campbell S; Michaelson J; Burkly L; Putterman C
    Front Biosci; 2004 Sep; 9():2273-84. PubMed ID: 15353286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
    Campbell S; Burkly LC; Gao HX; Berman JW; Su L; Browning B; Zheng T; Schiffer L; Michaelson JS; Putterman C
    J Immunol; 2006 Feb; 176(3):1889-98. PubMed ID: 16424220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury.
    Serafini B; Magliozzi R; Rosicarelli B; Reynolds R; Zheng TS; Aloisi F
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1137-48. PubMed ID: 19018248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWEAK and the central nervous system.
    Yepes M
    Mol Neurobiol; 2007 Jun; 35(3):255-65. PubMed ID: 17917114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWEAK and Fn14. New players in the pathogenesis of atherosclerosis.
    Blanco-Colio LM; Martín-Ventura JL; Munoz-Garcia B; Moreno JA; Meilhac O; Ortiz A; Egido J
    Front Biosci; 2007 May; 12():3648-55. PubMed ID: 17485328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease.
    Gomez IG; Roach AM; Nakagawa N; Amatucci A; Johnson BG; Dunn K; Kelly MC; Karaca G; Zheng TS; Szak S; Peppiatt-Wildman CM; Burkly LC; Duffield JS
    J Am Soc Nephrol; 2016 Dec; 27(12):3639-3652. PubMed ID: 27026366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
    Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
    Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus.
    Doerner JL; Wen J; Xia Y; Paz KB; Schairer D; Wu L; Chalmers SA; Izmirly P; Michaelson JS; Burkly LC; Friedman AJ; Putterman C
    J Invest Dermatol; 2015 Aug; 135(8):1986-1995. PubMed ID: 25826425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No end in site: TWEAK/Fn14 activation and autoimmunity associated- end-organ pathologies.
    Zheng TS; Burkly LC
    J Leukoc Biol; 2008 Aug; 84(2):338-47. PubMed ID: 18483204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.